zevra therapeutics：Investor Relations
Investor Relations
About Us
https://zevra.com
We are a rare disease therapeutics company leading with science to make life-changing therapeutics available to patients with significant unmet needs.
Acer Therapeutics
https://zevra.com
Zevra Therapeutics to Acquire Acer Therapeutics, Expanding its Rare Disease Portfolio and Adding Commercial Product. Press Release Investor Webcast.
Careers
https://zevra.com
We are a hard-working herd, the real zeal and a dazzling group of professionals. Join our herd!
Press Releases
https://investors.zevra.com
Zevra Therapeutics to Report First Quarter 2023 Results on May 15, 2023. 05-09-2023. Zevra Announces Board of Directors and Leadership Changes. 05-08-2023.
Science & Pipeline
https://zevra.com
Our expertise, elegant solutions, and transparent data narratives have produced a late-stage rare disease clinical pipeline and two partnered ...
Zevra Therapeutics
https://zevra.com
We are a nimble rare disease therapeutics company comprised of expert scientists, patient advocates, development strategists, commercialization specialists, and ...
Zevra Therapeutics, Inc. (ZVRA) Stock Price
https://finance.yahoo.com
Find the latest Zevra Therapeutics, Inc. (ZVRA) stock quote, history, news and other vital information to help you with your stock trading and investing.